Volume 162, Issue 3

Search all Journal of Neuro-Oncology articles

May 2023

Special Issue: Diagnostic and Therapeutic Implications of IDH Mutations in Gliomas Following the 2021 World Health Organization Classification of CNS Tumors

Issue Editors:

Tareq A. Juratli,
Christine Jungk,
Julie J. Miller

9 articles in this issue

Journal of Neuro Oncology: Diagnostic and therapeutic implications of IDH mutations in gliomas following the 2021 World Health Organization classification of CNS tumors
Tareq A. Juratli
Christine Jungk
Julie J. Miller
Review Open access 22 May 2023 Pages: 457 - 459
Part of 1 collection:

Special Issue: Diagnostic and therapeutic implications of IDH mutations in gliomas following the 2021 World Health Organization classification of CNS tumors
Updates on the WHO diagnosis of IDH-mutant glioma
David.E. Reuss
Review Open access 30 January 2023 Pages: 461 - 469
Part of 1 collection:

Special Issue: Diagnostic and therapeutic implications of IDH mutations in gliomas following the 2021 World Health Organization classification of CNS tumors
Conventional and emerging treatments of astrocytomas and oligodendrogliomas
Tobias Kessler
Jakob Ito
Antje Wick
Review Open access 25 December 2022 Pages: 471 - 478
Part of 1 collection:

Special Issue: Diagnostic and therapeutic implications of IDH mutations in gliomas following the 2021 World Health Organization classification of CNS tumors
Publisher’s Note
Springer Science + Business Media LLC
Publisher's Note 22 May 2023 Pages: 479 - 479
Clinical applications and prospects of PET imaging in patients with IDH-mutant gliomas
Michael M. Wollring
Jan-Michael Werner
Norbert Galldiks
Review Open access 29 December 2022 Pages: 481 - 488
Part of 1 collection:

Special Issue: Diagnostic and therapeutic implications of IDH mutations in gliomas following the 2021 World Health Organization classification of CNS tumors
Analysis of safety and efficacy of proton radiotherapy for IDH-mutated glioma WHO grade 2 and 3
Tanja Eichkorn
Jonathan W. Lischalk
Laila König
Case Study Open access 04 January 2023 Pages: 489 - 501
Part of 1 collection:

Special Issue: Diagnostic and therapeutic implications of IDH mutations in gliomas following the 2021 World Health Organization classification of CNS tumors
Proton radiotherapy in the treatment of IDH-mutant diffuse gliomas: an early experience from shanghai proton and heavy ion center
Xianxin Qiu
Jing Gao
Lin Kong
Research 30 December 2022 Pages: 503 - 514
Part of 1 collection:

Special Issue: Diagnostic and therapeutic implications of IDH mutations in gliomas following the 2021 World Health Organization classification of CNS tumors
DNA damage in IDH-mutant gliomas: mechanisms and clinical implications
Diana D. Shi
Soummitra Anand
Samuel K. McBrayer
Review 09 November 2022 Pages: 515 - 523
Part of 1 collection:

Special Issue: Diagnostic and therapeutic implications of IDH mutations in gliomas following the 2021 World Health Organization classification of CNS tumors
Cognitive issues in patients with IDH mutant gliomas: from neuroscience to clinical neuropsychology
Michael W. Parsons
David S. Sabsevitz
Review 20 March 2023 Pages: 525 - 533
Part of 1 collection:

Special Issue: Diagnostic and therapeutic implications of IDH mutations in gliomas following the 2021 World Health Organization classification of CNS tumors

Volume 162, Issue 3

Search

Navigation